These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 382532)

  • 21. The use of antilymphocyte globulin in renal allograft rejection. A controlled study.
    Birkeland SA
    Postgrad Med J; 1976; 52(5 Suppl):82-8. PubMed ID: 792853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Individualization of recipient immunosuppression by use of in vitro monitoring parameters.
    Thomas F; Thomas J; Mendez G; Lee HM; Lower R
    Transplant Proc; 1978 Sep; 10(3):621-5. PubMed ID: 362647
    [No Abstract]   [Full Text] [Related]  

  • 23. Sequential monitoring of immunoregulatory T cell subsets in renal transplantation.
    Mestre M; González C; Griño JM; Valls A; Bonete J; Mané E; Corominas M; Bas J; Romeu A; Buendia E
    Transplant Proc; 1992 Feb; 24(1):73-5. PubMed ID: 1539351
    [No Abstract]   [Full Text] [Related]  

  • 24. Rejection episodes and lymphocyte responses in patients treated with rabbit antithymocyte sera.
    Cardella CJ; Landsberg D; Ng CM
    Transplant Proc; 1984 Aug; 16(4):1089-92. PubMed ID: 6235651
    [No Abstract]   [Full Text] [Related]  

  • 25. Early, low dose rabbit ALG therapy in cadaver kidney transplantation.
    Mannick JA; Nabseth DC; Olsson CA; Davis RC
    Transplant Proc; 1972 Dec; 4(4):497-9. PubMed ID: 4566794
    [No Abstract]   [Full Text] [Related]  

  • 26. Effective monitoring and modulation of immune reactivity in allograft recipients.
    Thomas F; Lee HM; Thomas J; Mendez-Picon G
    Proc Clin Dial Transplant Forum; 1976 Nov 19-22; 6():20-6. PubMed ID: 801063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental kidney transplantation.
    Murphy GP; Grafton TS
    Lab Anim Sci; 1973 Feb; 23(1):97-102. PubMed ID: 4347767
    [No Abstract]   [Full Text] [Related]  

  • 28. New approaches to the use of antibodies for immunosuppression.
    Russell PS
    Transplant Proc; 1982 Sep; 14(3):506-8. PubMed ID: 6758236
    [No Abstract]   [Full Text] [Related]  

  • 29. Mitigation of hyperacute rejection by antilymphocyte globulin (ALG).
    Hammer C; Krebs G; Chaussy C; Pfeifer K; Schmidt K; Land W; Brendel W
    Transplant Proc; 1979 Mar; 11(1):31-5. PubMed ID: 377651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lymphocytic molecules implicated in rosette phenomenon. Differential effect of antilymphocyte serum on T (CD2+E2+) and B (CD2-E2+) lymphocytes].
    Ticchioni M; Bernard-Pomier G; Cassuto-Viguier E; Zoccola D; Allieri-Rosenthal MA; Vivinus M; Bernard A
    Therapie; 1992; 47(4):293-6. PubMed ID: 1494790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
    Wieneke H; Otte B; Lang D; Heidenreich S
    Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized prospective clinical trial of antilymphocyte globulin in 100 cadaveric renal transplants.
    Sansom JR; Barnes AD; Hall CL
    Postgrad Med J; 1976; 52(5 Suppl):75-8. PubMed ID: 792851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conversion of cyclosporine to azathioprine in renal transplant patients.
    Shen SY; Zemel SM; Weir MR; Dagher FJ; Bentley FR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2032-6. PubMed ID: 3547906
    [No Abstract]   [Full Text] [Related]  

  • 34. Mechanisms of immunosuppression by antilymphocyte antibody.
    Taub RN
    Pathobiol Annu; 1972; 2():129-51. PubMed ID: 4149315
    [No Abstract]   [Full Text] [Related]  

  • 35. Does suppression of T-RFC determine in vivo immunosuppressive effect of ATG?
    Geis WP; Giacchino JL; Buckingham JM; Bansal VK; Iwatsuki S; Kerman RH; Ing TS; Hano JE
    Transplant Proc; 1979 Jun; 11(2):1433-4. PubMed ID: 382533
    [No Abstract]   [Full Text] [Related]  

  • 36. Alternative antirejection treatment with steroids or antilymphoblast globulin in renal transplant patients receiving cyclosporine.
    Veremis SA; Maddux MS; Pollak R; Kline SS; Mozes MF
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1893-5. PubMed ID: 3079056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rejection prophylaxis with antilymphocyte globulin for cardiac transplantation in Oriental recipients.
    Wei J; Chang CY; Lee FY; Song YB; Jiau SF
    Transplant Proc; 1992 Aug; 24(4):1493-7. PubMed ID: 1496632
    [No Abstract]   [Full Text] [Related]  

  • 38. An evaluation of early cyclosporine versus ALG therapy for primary cadaver renal allografts with immediate function.
    Adams MB; Johnson CP; Roza AM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1606-8. PubMed ID: 2652523
    [No Abstract]   [Full Text] [Related]  

  • 39. Experience with antilymphocyte globulin in 144 renal transplant recipients.
    Lundgren G; Collste L; Groth CG; Krzymansky M; Magnusson G; Quadracci L; Ringdén O; Svehag SE
    Postgrad Med J; 1976; 52(5 Suppl):67-71. PubMed ID: 792849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of DNA synthesis in lymphocytes from ALG-treated patients.
    Möller G; Lundgren G
    Clin Exp Immunol; 1970 Feb; 6(2):299-304. PubMed ID: 4907964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.